您好,欢迎来到化工原料网! [登录] [免费注册]
化工原料网
位置:首页 > 产品库 > Bafrekalant
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Bafrekalant
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Bafrekalant图片
CAS NO:2256770-44-0
包装与价格:
包装价格(元)
5mg电议
10mg电议

产品介绍
Bafrekalant 是一种二氮杂双环取代的咪唑并[1,2-a]嘧啶衍生物。Bafrekalant 具有研究呼吸障碍的潜力,包括与睡眠相关的呼吸障碍,如阻塞性和中枢性睡眠呼吸暂停和打鼾 (信息提取自专利 WO2018228907A1)。
Cas No.2256770-44-0
分子式C29H31ClN6O2
分子量531.05
溶解度DMSO : 250 mg/mL (470.77 mM; Need ultrasonic)
储存条件Store at -20°C
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
产品描述

Bafrekalant is a diazabicyclic substituted imidazo[l,2-a]pyrimidine-derivative. Bafrekalant has the potential for the research of breathing disorders, including sleep-related breathing disorders such as obstructive and central sleep apnea and snoring (extracted from patent WO2018228907A1).

[1]. Martina Delbeck, et al. Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disorders. Patent WO2018228907A1.